![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 350.59 | MF: C9H11Cl3NO3PS |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
mouse
other cell types
|
500 µg/L
|
MUREAV 279,165,1992
|
DNA damage
|
human
liver
|
10 µmol/L
|
TOXID9 -,73,2008
|
DNA damage
|
oral | mouse
0.28 mg/kg
|
MUREAV 516,139,2002
|
DNA inhibition
|
human
other cell types
|
3 µmol/L/1 hour
|
TXAPA9 206,17,2005
|
sister chromatid exchange
|
human
lymphocyte
|
2 mg/L
|
MUREAV 102,89,1982
|
sister chromatid exchange
|
mouse
other cell types
|
1 mg/L
|
MUREAV 279,165,1992
|
sex chromosome loss and nondisjunction
|
oral | Drosophila melanogaster
50 ppb
|
ENMUDM 5,835,1983
|
specific locus test
|
oral | Drosophila melanogaster
50 ppb
|
MUREAV 279,15,1992
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 80 mg/kg (1 day prior to copulation)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material)
|
REPTED 17,401,2003
|
intraperitoneal | mouse
lowest published toxic dose: 40 mg/kg (10 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
REPTED 20,267,2005
|
intraperitoneal | mouse
lowest published toxic dose: 80 mg/kg (10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
REPTED 20,267,2005
|
intraperitoneal | rat
lowest published toxic dose: 210 µg/kg (1-7 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
VHTODE 34,498,1992
|
intraperitoneal | rat
lowest published toxic dose: 4,500 µg/kg (7-21 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
VHTODE 34,498,1992
|
oral | mouse
lowest published toxic dose: 250 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TXAPA9 54,31,1980
|
oral | mouse
lowest published toxic dose: 6 mg/kg (multigenerations)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
REPTED 22,263,2006
|
oral | mouse
lowest published toxic dose: 24 mg/kg (15-18 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
REPTED 22,263,2006
|
oral | mouse
lowest published toxic dose: 12 mg/kg (15-18 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic | Reproductive: Effects on newborn: Behavioral
TOSCF2 93,105,2006
|
oral | pigeon
lowest published toxic dose: 35 mg/kg (7 day prior to copulation)
|
Reproductive: Effects on fertility: Other measures of fertility | Reproductive: Other effects to embryo or fetus Reproductive: Effects on newborn: Other neonatal measures or effects
TOXID9 -,14,2008
|
oral | rat
lowest published toxic dose: 25 mg/kg (14-18 day pregnant)
|
Reproductive: Other effects on female
|
TOSCF2 52,92,1999
|
oral | rat
lowest published toxic dose: 135 mg/kg (6-22 day pregnant/10 day after birth)
|
Reproductive: Other effects on female | Reproductive: Effects on newborn: Biochemical and metabolic
TOSCF2 53,438,2000
|
oral | rat
lowest published toxic dose: 250 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
REPTED 17,203,2003
|
oral | rat
lowest published toxic dose: 250 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Hepatobiliary system
REPTED 17,203,2003
|
oral | rat
lowest published toxic dose: 250 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear
|
REPTED 17,203,2003
|
oral | rat
lowest published toxic dose: 150 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
REPTED 17,203,2003
|
oral | rat
lowest published toxic dose: 45 mg/kg (6-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Biochemical and metabolic
TOSCF2 77,83,2004
|
oral | rat
lowest published toxic dose: 75 mg/kg (6-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
TOXID9 66,131,2002
|
oral | rat
lowest published toxic dose: 8 mg/kg (14 day pregnant-7 day after birth)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow) Reproductive: Specific developmental abnormalities: Hepatobiliary system
TOXID9 66,138,2002
|
oral | rat
lowest published toxic dose: 5 mg/kg (14-18 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 66,130,2002
|
oral | rat
lowest published toxic dose: 50 mg/kg (14 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
ARTODN 76,30,2002
|
oral | rat
lowest published toxic dose: 45 mg/kg (6-20 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
TOXID9 60,240,2001
|
oral | rat
lowest published toxic dose: 252 mg/kg (1-21 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
JTSCDR 31,521,2006
|
oral | rat
lowest published toxic dose: 315 mg/kg (1-21 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
JTSCDR 31,521,2006
|
oral | rat
lowest published toxic dose: 180 mg/kg (6-15 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
INJPD2 39,145,2007
|
oral | rabbit
lowest published toxic dose: 12,180 mg/kg (6-19 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
FEREAC 60,7509,1995
|
subcutaneous | mouse
lowest published toxic dose: 180 mg/kg (6-17 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TERPM* -,394,2006
|
subcutaneous | mouse
lowest published toxic dose: 15 mg/kg (17-20 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
TOXID9 12,466,2008
|
subcutaneous | rat
lowest published toxic dose: 200 mL/kg (12 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Specific developmental abnormalities: Central nervous system
JTEHD6 44,189,1995
|
subcutaneous | rat
lowest published toxic dose: 50 mg/kg (12-19 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Other effects to embryo or fetus
PBBHAU 53,771,1996
|
subcutaneous | rat
lowest published toxic dose: 200 mg/kg (12-19 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Behavioral
PBBHAU 53,771,1996
|
subcutaneous | rat
lowest published toxic dose: 4 mg/kg (17-20 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic | Reproductive: Effects on newborn: Drug dependence
NETEEC 24,733,2002
|
subcutaneous | rat
lowest published toxic dose: 4 mg/kg (9-12 day pregnant)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Delayed effects
NETEEC 26,95,2004
|
subcutaneous | rat
lowest published toxic dose: 20 mg/kg (17-20 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 66,130,2002
|
skin | rat
lowest published toxic dose: 30 mg/kg (18 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Central nervous system
JTEHD6 63,173,2001
|
skin | rat
lowest published toxic dose: 1.6 mg/kg (5-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow)
TOXID9 72,127,2003
|
skin | rat
lowest published toxic dose: 1.7 mg/kg (4-20 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic | Reproductive: Effects on newborn: Delayed effects
TOXID9 78,274,2004
|
skin | rat
lowest published toxic dose: 1.7 mg/kg (4-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Biochemical and metabolic Reproductive: Effects on newborn: Delayed effects
ARTODN 78,467,2004
|
skin | rat
lowest published toxic dose: 17 mg/kg (4-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Biochemical and metabolic Reproductive: Effects on newborn: Behavioral
TOXID9 90,295,2006
|
skin | rat
lowest published toxic dose: 17 mg/kg (4-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Behavioral Reproductive: Effects on newborn: Delayed effects
ARTODN 80,620,2006
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lethal concentration (50 percent kill): >0.2 gm/m3/4 hour
|
N/R
|
ENTOX* -,583,2005
|
intraperitoneal | mouse
lethal dose (50 percent kill): 192 mg/kg
|
N/R
|
TXAPA9 65,144,1982
|
intraperitoneal | mouse
lowest published toxic dose: 30 mg/kg
|
Brain and Coverings: Other degenerative changes
|
TOLED5 135,89,2002
|
intraperitoneal | mouse
lowest published toxic dose: 10 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
TXAPA9 205,149,2005
|
intraperitoneal | mouse
lowest published toxic dose: 30 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Change in motor activity (specific assay) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXAPA9 211,78,2006
|
intraperitoneal | mouse
lowest published toxic dose: 30 mg/kg
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
TXAPA9 224,98,2007
|
intraperitoneal | mouse
lowest published toxic dose: 100 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Tremor
TXAPA9 227,42,2008
|
intraperitoneal | non-mammalian species
lowest published toxic dose: 2 mg/kg
|
Blood: Changes in spleen | Blood: Changes in leukocyte (WBC) count Immunological Including Allergic: Increase in cellular immune response
TOXID9 78,321,2004
|
intraperitoneal | non-mammalian species
lowest published toxic dose: 50 mg/kg
|
Kidney, Ureter, and Bladder: Other changes | Immunological Including Allergic: Decreased immune response Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOXID9 78,321,2004
|
intraperitoneal | rat
lowest published toxic dose: 15 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,312,2002
|
multiple | man
lowest published toxic concentration: 45 pph/15 minute
|
Peripheral Nerve and Sensation: Sensory change involving peripheral nerve | Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) Gastrointestinal: Nausea or vomiting
JTCTDW 41,883,2003
|
oral | wild bird
lethal dose (50 percent kill): 5 mg/kg
|
N/R
|
TXAPA9 21,315,1972
|
oral | chicken
lethal dose (50 percent kill): 25,400 µg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Somnolence (general depressed activity) Behavioral: Convulsions or effect on seizure threshold
TXAPA9 11,49,1967
|
oral | chicken
lowest published toxic dose: 150 mg/kg
|
Behavioral: Ataxia
|
ARTODN 76,367,2002
|
oral | chicken
lethal dose (50 percent kill): 18.14 mg/kg
|
N/R
|
TOLED5 174,110,2007
|
oral | chicken
lowest published toxic dose: 5 mg/kg
|
Eye: Lacrimation | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
TOLED5 174,110,2007
|
oral | chicken
lowest published toxic dose: 2 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Change in motor activity (specific assay) Behavioral: Alteration of classical conditioning
TOLED5 174,110,2007
|
oral | duck
lethal dose (50 percent kill): 76 mg/kg
|
N/R
|
TXAPA9 20,57,1971
|
oral | dog
lowest published toxic dose: 1 mg/kg
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,311,2002
|
oral | guinea pig
lethal dose (50 percent kill): 504 mg/kg
|
N/R
|
FMCHA2 -,C74,1991
|
oral | guinea pig
lowest published lethal dose: 299 mg/kg
|
N/R
|
RTOPDW 35,105,2002
|
oral | human
lowest published toxic dose: 2 mg/kg
|
Endocrine: Differential effect of sex or castration on observed toxicity | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TOSCF2 66,34,2002
|
oral | man
lowest published toxic dose: 300 mg/kg
|
Peripheral Nerve and Sensation: Paresthesia | Behavioral: Muscle weakness Behavioral: Coma
ARTODN 59,176,1986
|
oral | man
lowest published toxic dose: 1.71 mL/kg
|
Behavioral: Muscle weakness | Vascular: BP lowering not characterized in autonomic section Lung, Thorax, or Respiration: Respiratory depression
VHTODE 43,34,2001
|
oral | mouse
lowest published toxic dose: 25 mg/kg
|
Brain and Coverings: Other degenerative changes | Peripheral Nerve and Sensation: Fasciculations Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXCYAC 234,90,2007
|
oral | mouse
lethal dose (50 percent kill): 60 mg/kg
|
N/R
|
TXCYAC 234,90,2007
|
oral | mouse
lethal dose (50 percent kill): 75 mg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TXCYAC 234,90,2007
|
oral | mouse
lowest published toxic dose: 10 mg/kg
|
Liver: Liver function tests impaired | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
FCTOD7 46,797,2008
|
oral | pigeon
lethal dose (50 percent kill): 10 mg/kg
|
N/R
|
ASTTA8 (680),157,1979
|
oral | quail
lethal dose (50 percent kill): 13,300 µg/kg
|
N/R
|
ASTTA8 (680),157,1979
|
oral | rat
lethal dose (50 percent kill): 82 mg/kg
|
N/R
|
TXAPA9 14,515,1969
|
oral | rat
lowest published toxic dose: 23.5 mg/kg
|
Brain and Coverings: Other degenerative changes | Autonomic Nervous System: Other (direct) parasympathomimetic Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NRTXDN 22,39,2001
|
oral | rat
lowest published toxic dose: 25 mg/kg
|
Behavioral: Change in psychophysiological tests
|
TXCYAC 146,1,2000
|
oral | rat
lowest published toxic dose: 1 mg/kg
|
Nutritional and Gross Metabolic: Body temperature increase
|
TXCYAC 177,215,2002
|
oral | rat
lowest published toxic dose: 5 mg/kg
|
Brain and Coverings: Other degenerative changes
|
TOXID9 72,305,2003
|
oral | rat
lowest published lethal dose: 8 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 72,308,2003
|
oral | rat
lowest published toxic dose: 10 mg/kg
|
Nutritional and Gross Metabolic: Body temperature decrease
|
TOXID9 72,308,2003
|
oral | rat
lowest published toxic dose: 5 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 72,309,2003
|
oral | rat
lowest published toxic dose: 10 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TOSCF2 66,34,2002
|
oral | rat
lowest published toxic dose: 1.5 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOSCF2 77,63,2004
|
oral | rat
lowest published lethal dose: 69 mg/kg
|
N/R
|
RTOPDW 35,105,2002
|
oral | rat
lowest published toxic dose: 30 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Nutritional and Gross Metabolic: Body temperature decrease
TOXID9 66,35,2002
|
oral | rat
lowest published toxic dose: 50 mg/kg
|
Behavioral: Tremor | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
ARTODN 76,30,2002
|
oral | rat
lowest published toxic dose: 1.5 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,312,2002
|
oral | rat
lethal dose (40 percent kill): 80 mg/kg
|
N/R
|
TOXID9 66,313,2002
|
oral | rat
lethal dose (10 percent kill): 136 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 60,241,2001
|
oral | rat
lowest published toxic dose: 15 mg/kg
|
Brain and Coverings: Other degenerative changes | Blood: Other changes Nutritional and Gross Metabolic: Body temperature decrease
TOXID9 60,246,2001
|
oral | rat
lowest published toxic dose: 1 mg/kg
|
Behavioral: Change in motor activity (specific assay)
|
TOXID9 60,246,2001
|
oral | rat
lowest published toxic dose: 10 mg/kg
|
Brain and Coverings: Changes in surface EEG
|
TOXID9 60,246,2001
|
oral | rat
lowest published lethal dose: 8 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TXAPA9 210,142,2006
|
oral | rat
lowest published toxic dose: 3 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
|
TXCYAC 217,1,2006
|
oral | rat
lowest published toxic dose: 30 mg/kg
|
Gastrointestinal: Changes in structure or function of salivary glands | Nutritional and Gross Metabolic: Body temperature decrease Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TXCYAC 217,1,2006
|
oral | rat
lowest published toxic dose: 2.4 mg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOVEFN (3),15,1993
|
oral | rat
lowest published toxic dose: 2 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Somnolence (general depressed activity) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 210,142,2006
|
oral | rat
lowest published lethal dose: 10 mg/kg
|
Peripheral Nerve and Sensation: Fasciculations | Gastrointestinal: Hypermotility, diarrhea
TXCYAC 220,13,2006
|
oral | rat
lowest published toxic dose: 1 mg/kg
|
Brain and Coverings: Other degenerative changes | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXCYAC 220,13,2006
|
oral | rat
lowest published toxic dose: 60 mg/kg
|
Peripheral Nerve and Sensation: Fasciculations | Gastrointestinal: Hypermotility, diarrhea
TXAPA9 205,31,2005
|
oral | rat
lowest published toxic dose: 68 mg/kg
|
Peripheral Nerve and Sensation: Fasciculations | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXCYAC 238,157,2007
|
oral | rat
lowest published toxic dose: 7.5 mg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXCYAC 238,157,2007
|
oral | rat
lowest published toxic dose: 15 mg/kg
|
Peripheral Nerve and Sensation: Fasciculations
|
TXCYAC 238,157,2007
|
oral | rat
lowest published lethal dose: 50 mg/kg
|
Behavioral: Sleep | Behavioral: Tremor
TXCYAC 237,145,2007
|
oral | rat
lowest published toxic dose: 5 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase | Eye: Miosis (pupilliary constriction)
TOSCF2 92,235,2006
|
oral | rat
lowest published toxic dose: 20 mg/kg
|
Behavioral: Alteration of classical conditioning | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOSCF2 92,235,2006
|
oral | rat
lowest published toxic dose: 25 mg/kg
|
Cardiac: Pulse rate increased without fall in BP | Vascular: BP elevation not characterized in autonomic section Nutritional and Gross Metabolic: Body temperature decrease
BCLPT* 96,503,2005
|
oral | rabbit
lowest published lethal dose: 1,000 mg/kg
|
N/R
|
RTOPDW 35,105,2002
|
oral | rabbit
lethal dose (50 percent kill): 1 gm/kg
|
N/R
|
ENTOX* -,583,2005
|
oral | woman
lowest published toxic dose: 0.33 mL/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis with appropriate anesthesia | Eye: Miosis (pupilliary constriction) Gastrointestinal: Hypermotility, diarrhea
TOLED5 159,235,2005
|
oral | woman
lowest published toxic dose: 3 mL/kg
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Behavioral: Rigidity (includes catalepsy) Gastrointestinal: Nausea or vomiting
CTOXAO 43,877,2005
|
subcutaneous | guinea pig
lowest published lethal dose: 100 mg/kg
|
N/R
|
JEENAI 60,733,1967
|
subcutaneous | guinea pig
lowest published toxic dose: 390 mg/kg
|
Brain and Coverings: Other degenerative changes | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 60,242,2001
|
subcutaneous | rat
lowest published toxic dose: 60 mg/kg
|
Brain and Coverings: Other degenerative changes
|
TOXID9 72,305,2003
|
subcutaneous | rat
lowest published toxic dose: 13.5 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
NETEEC 25,599,2003
|
subcutaneous | rat
lowest published toxic dose: 45 mg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NETEEC 25,599,2003
|
subcutaneous | rat
lowest published toxic dose: 166 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Alteration of classical conditioning Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NETEEC 26,305,2004
|
subcutaneous | rat
lowest published toxic dose: 60 mg/kg
|
Behavioral: Change in motor activity (specific assay)
|
TOXID9 66,316,2002
|
subcutaneous | rat
lowest published toxic dose: 2.5 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JPETAB 305,375,2003
|
subcutaneous | rat
lowest published toxic dose: 84 mg/kg
|
Brain and Coverings: Recordings from specific areas of CNS | Nutritional and Gross Metabolic: Body temperature decrease Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 90,301,2006
|
subcutaneous | rat
lowest published toxic dose: 84 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Change in motor activity (specific assay) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 216,150,2006
|
subcutaneous | rat
lowest published toxic dose: 60 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 219,136,2007
|
subcutaneous | rat
lowest published toxic dose: 250 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of classical conditioning Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NRTXDN 28,541,2007
|
subcutaneous | rat
lowest published toxic dose: 250 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
TOLED5 176,162,2008
|
subcutaneous | rat
lowest published toxic dose: 60 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
JTEHF8 67,431,2004
|
skin | mouse
lethal dose (50 percent kill): 120 mg/kg
|
N/R
|
YKYUA6 38,745,1987
|
skin | mouse
lowest published toxic dose: 100 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOLED5 151,219,2004
|
skin | rat
lethal dose (50 percent kill): 202 mg/kg
|
N/R
|
TXAPA9 14,515,1969
|
skin | rat
lowest published toxic dose: 30 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord)
JTEHD6 63,173,2001
|
skin | rabbit
lethal dose (50 percent kill): 2,000 mg/kg
|
N/R
|
USXXAM #6193990
|
unreported route | mammal (species unspecified)
lethal dose (50 percent kill): 163 mg/kg
|
N/R
|
JAFCAU 27,712,1979
|
unreported route | rat
lethal dose (50 percent kill): 150 mg/kg
|
N/R
|
30ZDA9 -,339,1971
|
unreported route | rat
lowest published toxic dose: 1 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other
TOXID9 44,197,2005
|
unreported route | rat
lowest published toxic dose: 279 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 60,241,2001
|
unreported route | rat
lowest published toxic dose: 279 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Metabolism (intermediary): Other
TOXID9 60,241,2001
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | chicken
lowest published toxic dose: 980 mg/kg/2 week- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 11,49,1967
|
oral | chicken
lowest published toxic dose: 28 mg/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOLED5 174,110,2007
|
oral | dog
lowest published toxic dose: 2,190 mg/kg/2 year- continuous
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
FCTXAV 12,47,1974
|
oral | dog
lowest published toxic dose: 2,190 mg/kg/2 year- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
RTOPDW 35,105,2002
|
oral | dog
lowest published toxic dose: 7 mg/kg/1 week- continuous
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,311,2002
|
oral | dog
lowest published toxic dose: 84 mg/kg/6 week- continuous
|
Cardiac: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,311,2002
|
oral | dog
lowest published toxic dose: 8.4 mg/kg/4 week- continuous
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,312,2002
|
oral | dog
lowest published toxic dose: 365 mg/kg/1 year- continuous
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 60,322,2001
|
oral | mouse
lowest published toxic dose: 39.6 mg/kg/30 day- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
FCTOD7 41,767,2003
|
oral | mouse
lowest published toxic dose: 79.2 mg/kg/60 day- continuous
|
Blood: Normocytic anemia | Blood: Luekopenia
FCTOD7 41,767,2003
|
oral | mouse
lowest published toxic dose: 24 mg/kg/4 day- intermittent
|
Endocrine: Evidence of thyroid hypofunction
|
REPTED 22,263,2006
|
oral | mouse
lowest published toxic dose: 125 mg/kg/5 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TXCYAC 234,90,2007
|
oral | mouse
lowest published toxic dose: 93.6 mg/kg/30 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXCYAC 234,90,2007
|
oral | mouse
lowest published toxic dose: 31.25 mg/kg/5 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXCYAC 234,90,2007
|
oral | mouse
lowest published toxic dose: 15.6 mg/kg/5 day- intermittent
|
Liver: Other changes | Endocrine: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXCYAC 234,90,2007
|
oral | mouse
lowest published toxic dose: 639 mg/kg/10 week- intermittent
|
Blood: Luekopenia | Blood: Changes in erythrocyte (RBC) count Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
JTSCDR 32,111,2007
|
oral | mouse
lowest published toxic dose: 447.3 mg/kg/7 week- intermittent
|
Behavioral: Tremor | Lung, Thorax, or Respiration: Dyspnea Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JTSCDR 32,111,2007
|
oral | rat
lowest published toxic dose: 730 mg/kg/2 year- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
FCTXAV 12,47,1974
|
oral | rat
lowest published toxic dose: 21,840 µg/kg/28 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
ESKHA5 (106),48,1988
|
oral | rat
lowest published toxic dose: 800 mg/kg/8 week- intermittent
|
Eye: Miosis (pupilliary constriction) | Behavioral: Somnolence (general depressed activity) Behavioral: Tremor
TOXID9 36(1 Pt2),345,1997
|
oral | rat
lowest published toxic dose: 210 mg/kg/2 week- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TOSCF2 55,124,2000
|
oral | rat
lowest published toxic dose: 60 mg/kg/4 week- intermittent
|
Eye: Miosis (pupilliary constriction) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NETEEC 22,237,2000
|
oral | rat
lowest published toxic dose: 200 mg/kg/4 week- intermittent
|
Behavioral: Tremor | Behavioral: Alteration of operant conditioning Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NETEEC 22,237,2000
|
oral | rat
lowest published toxic dose: 50 mg/kg/5 day- intermittent
|
Eye: Miosis (pupilliary constriction) | Gastrointestinal: Changes in structure or function of salivary glands Nutritional and Gross Metabolic: Body temperature increase
NETEEC 22,237,2000
|
oral | rat
lowest published toxic dose: 50 mg/kg/3 day- intermittent
|
Behavioral: Alteration of operant conditioning | Behavioral: Change in motor activity (specific assay) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NETEEC 23,33,2001
|
oral | rat
lowest published toxic dose: 57 mg/kg/12 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOSCF2 59,260,2001
|
oral | rat
lowest published toxic dose: 111 mg/kg/21 day- intermittent
|
Behavioral: Change in motor activity (specific assay)
|
TOSCF2 59,260,2001
|
oral | rat
lowest published toxic dose: 18 mg/kg/6 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOSCF2 59,260,2001
|
oral | rat
lowest published toxic dose: 213 mg/kg/24 week- intermittent
|
Behavioral: Change in motor activity (specific assay) | Nutritional and Gross Metabolic: Body temperature decrease Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXCYAC 177,215,2002
|
oral | rat
lowest published toxic dose: 127.5 mg/kg/24 week- intermittent
|
Biochemical: Metabolism (intermediary): Plasma proteins not involving coagulation
|
TXCYAC 177,215,2002
|
oral | rat
lowest published toxic dose: 15 mg/kg/15 day- intermittent
|
Nutritional and Gross Metabolic: Body temperature increase
|
TXCYAC 177,215,2002
|
oral | rat
lowest published toxic dose: 75 mg/kg/5 day- intermittent
|
Behavioral: Tremor | Gastrointestinal: Changes in structure or function of salivary glands Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
REPTED 17,203,2003
|
oral | rat
lowest published toxic dose: 75 mg/kg/5 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
REPTED 17,203,2003
|
oral | rat
lowest published toxic dose: 1,820 mg/kg/1 year- continuous
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 72,309,2003
|
oral | rat
lowest published toxic dose: 119 mg/kg/17 day- intermittent
|
Nutritional and Gross Metabolic: Body temperature increase
|
TXCYAC 177,215,2002
|
oral | rat
lowest published toxic dose: 9 mg/kg/5 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOSCF2 76,400,2003
|
oral | rat
lowest published toxic dose: 12 mg/kg/4 day- intermittent
|
Brain and Coverings: Other degenerative changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOSCF2 77,63,2004
|
oral | rat
lowest published toxic dose: 4.2 mg/kg/28 day- continuous
|
Endocrine: Changes in thyroid weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
FCTOD7 42,1269,2004
|
oral | rat
lowest published toxic dose: 4.2 mg/kg/28 day- continuous
|
Blood: Other changes
|
FCTOD7 42,1269,2004
|
oral | rat
lowest published toxic dose: 45 mg/kg/9 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
RTOPDW 35,105,2002
|
oral | rat
lowest published toxic dose: 21 mg/kg/21 day- intermittent
|
Behavioral: Alteration of classical conditioning | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 44,198,2005
|
oral | rat
lowest published toxic dose: 66 mg/kg/11 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other proteins Biochemical: Metabolism (intermediary): Other
TOXID9 44,199,2005
|
oral | rat
lowest published toxic dose: 21 mg/kg/21 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 44,199,2005
|
oral | rat
lowest published toxic dose: 79.5 mg/kg/21 day- intermittent
|
Biochemical: Metabolism (intermediary): Other
|
TOXID9 44,199,2005
|
oral | rat
lowest published toxic dose: 4.5 mg/kg/6 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,131,2002
|
oral | rat
lowest published toxic dose: 8 mg/kg/16 day- intermittent
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
TOXID9 66,138,2002
|
oral | rat
lowest published toxic dose: 53 mg/kg/21 day- intermittent
|
Behavioral: Alteration of operant conditioning | Endocrine: Differential effect of sex or castration on observed toxicity Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 78,273,2004
|
oral | rat
lowest published toxic dose: 120 mg/kg/24 day- intermittent
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TOXID9 78,276,2004
|
oral | rat
lowest published toxic dose: 42 mg/kg/31 day- intermittent
|
Brain and Coverings: Other degenerative changes | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 1,113,2001
|
oral | rat
lowest published toxic dose: 126 mg/kg/31 day- intermittent
|
Biochemical: Metabolism (intermediary): Other
|
TOXID9 1,113,2001
|
oral | rat
lowest published toxic dose: 30 mg/kg/5 day- intermittent
|
Behavioral: Change in motor activity (specific assay)
|
TOXID9 1,113,2001
|
oral | rat
lowest published toxic dose: 30 mg/kg/5 day- intermittent
|
Behavioral: Excitement
|
TOXID9 1,113,2001
|
oral | rat
lowest published toxic dose: 26 mg/kg/17 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
TOXID9 1,113,2001
|
oral | rat
lowest published toxic dose: 14 mg/kg/14 day- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,313,2002
|
oral | rat
lowest published toxic dose: 42 mg/kg/14 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,313,2002
|
oral | rat
lowest published toxic dose: 364 mg/kg/1 year- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,313,2002
|
oral | rat
lowest published toxic dose: 1,820 mg/kg/1 year- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Change in psychophysiological tests Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,313,2002
|
oral | rat
lowest published toxic dose: 270 mg/kg/1 year- intermittent
|
Eye: Retinal changes pigmentary deposition, retinitis, other)
|
TOXID9 60,245,2001
|
oral | rat
lowest published toxic dose: 80 mg/kg/20 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other proteins
TOXID9 90,295,2006
|
oral | rat
lowest published toxic dose: 378 mg/kg/8 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TOLED5 163,235,2006
|
oral | rat
lowest published toxic dose: 18 mg/kg/6 day- intermittent
|
Brain and Coverings: Other degenerative changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOSCF2 92,500,2006
|
oral | rat
lowest published toxic dose: 9 mg/kg/6 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
TOSCF2 92,500,2006
|
oral | rat
lowest published toxic dose: 315 mg/kg/21 day- intermittent
|
Olfaction: Other olfaction effects | Eye: Hemorrhage Behavioral: Tremor
JTSCDR 31,521,2006
|
oral | rat
lowest published toxic dose: 105 mg/kg/7 day- intermittent
|
Behavioral: Food intake (animal)
|
JTSCDR 31,521,2006
|
oral | rat
lowest published toxic dose: 252 mg/kg/21 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JTSCDR 31,521,2006
|
oral | rat
lowest published toxic dose: 378 mg/kg/8 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOLED5 169,26,2007
|
oral | rat
lowest published toxic dose: 180 mg/kg/9 day- intermittent
|
Liver: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport
INJPD2 39,145,2007
|
oral | rabbit
lowest published toxic dose: 1,960 mg/kg/13 day- intermittent
|
Behavioral: Food intake (animal) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FEREAC 60,7509,1995
|
subcutaneous | mouse
lowest published toxic dose: 300 mg/kg/2 week- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
NRTXDN 23,537,2002
|
subcutaneous | mouse
lowest published toxic dose: 4.5 mg/kg/2 week- intermittent
|
Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites
|
TOXID9 60,238,2001
|
subcutaneous | mouse
lowest published toxic dose: 300 mg/kg/2 week- intermittent
|
Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
|
TOXID9 60,238,2001
|
subcutaneous | mouse
lowest published toxic dose: 75 mg/kg/2 week- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Alteration of classical conditioning Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 60,242,2001
|
subcutaneous | mouse
lowest published toxic dose: 4 mg/kg/4 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOSCF2 93,105,2006
|
subcutaneous | mouse
lowest published toxic dose: 12 mg/kg/4 day- intermittent
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of classical conditioning Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOSCF2 93,105,2006
|
subcutaneous | mouse
lowest published toxic dose: 12 mg/kg/4 day- intermittent
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Aggression Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOSCF2 93,105,2006
|
subcutaneous | mouse
lowest published toxic dose: 4 mg/kg/4 day- intermittent
|
Behavioral: Alteration of classical conditioning | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOSCF2 93,105,2006
|
subcutaneous | mouse
lowest published toxic dose: 120 mg/kg/12 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TERPM* -,394,2006
|
subcutaneous | rat
lowest published toxic dose: 21 mg/kg/7 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
TXAPA9 174,89,2001
|
subcutaneous | rat
lowest published toxic dose: 0.6 mg/kg/5 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
TXAPA9 174,89,2001
|
subcutaneous | rat
lowest published toxic dose: 250 mg/kg/7 day- intermittent
|
Behavioral: Alteration of operant conditioning | Behavioral: Change in motor activity (specific assay) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NETEEC 23,33,2001
|
subcutaneous | rat
lowest published toxic dose: 120 mg/kg/1 hour/4 week- intermittent
|
Brain and Coverings: Other degenerative changes | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
ARTODN 75,480,2001
|
subcutaneous | rat
lowest published toxic dose: 120 mg/kg/42 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 72,305,2003
|
subcutaneous | rat
lowest published toxic dose: 160 mg/kg/16 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Metabolism (intermediary): Other
PBBHAU 46,219,1993
|
subcutaneous | rat
lowest published toxic dose: 20 mg/kg/4 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other proteins
TXAPA9 195,203,2004
|
subcutaneous | rat
lowest published toxic dose: 20 mg/kg/4 day- intermittent
|
Brain and Coverings: Other degenerative changes | Endocrine: Differential effect of sex or castration on observed toxicity Biochemical: Metabolism (intermediary): Other proteins
TXAPA9 203,132,2005
|
subcutaneous | rat
lowest published toxic dose: 20 mg/kg/4 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOXID9 66,130,2002
|
subcutaneous | rat
lowest published toxic dose: 20 mg/kg/4 day- intermittent
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of classical conditioning Behavioral: Alteration of operant conditioning
TOXID9 1,114,2001
|
subcutaneous | rat
lowest published toxic dose: 21 mg/kg/9 day- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Alteration of classical conditioning Biochemical: Metabolism (intermediary): Other
TOXID9 60,241,2001
|
subcutaneous | rat
lowest published toxic dose: 250 mg/kg/10 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JPETAB 305,375,2003
|
subcutaneous | rat
lowest published toxic dose: 300 mg/kg/6 day- intermittent
|
Behavioral: Tremor | Gastrointestinal: Changes in structure or function of salivary glands Gastrointestinal: Hypermotility, diarrhea
JPETAB 305,375,2003
|
subcutaneous | rat
lowest published toxic dose: 10 mg/kg/4 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
JPETAB 305,375,2003
|
subcutaneous | rat
lowest published toxic dose: 120 mg/kg/35 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOPADD 33,378,2005
|
skin | rat
lowest published toxic dose: 26 mg/kg/13 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
TOXID9 72,89,2003
|
skin | rat
lowest published toxic dose: 3 mg/kg/30 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
ARTODN 77,452,2003
|
skin | rat
lowest published toxic dose: 30 mg/kg/30 day- intermittent
|
Brain and Coverings: Other degenerative changes | Behavioral: Change in psychophysiological tests Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,314,2002
|
unreported route | rat
lowest published toxic dose: 4 mg/kg/4 day- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS
|
TOXID9 72,124,2003
|
unreported route | rat
lowest published toxic dose: 10.5 mg/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 72,309,2003
|
unreported route | rat
lowest published toxic dose: 15 mg/kg/5 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
TOXID9 72,309,2003
|
unreported route | rat
lowest published toxic dose: 4 mg/kg/4 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
TOXID9 44,197,2005
|
unreported route | rat
lowest published toxic dose: 4 mg/kg/4 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
TOXID9 66,130,2002
|
unreported route | rat
lowest published toxic dose: 20 mg/kg/4 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
|
TOXID9 60,241,2001
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.1 mg/m3 (inhalable, vapor, skin)
|
DTLVS* TLV/BEI,2007
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not classifiable as human carcinogen
|
DTLVS* TLV/BEI,2007
|
TOXICOLOGY REVIEW
|
|
MUREAV 539,77,2003
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,101,2002
|
TOXICOLOGY REVIEW
|
|
RREVAH 63,1,1976
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,29,2002
|
TOXICOLOGY REVIEW
|
|
PPTHFJ 42,55,2005
|
TOXICOLOGY REVIEW
|
|
REPTED 22,196,2006
|
TOXICOLOGY REVIEW
|
|
REPTED 22,164,2006
|
TOXICOLOGY REVIEW
|
|
MUTAEX 21,93,2006
|
TOXICOLOGY REVIEW
|
|
APHRER 40,1040,2006
|
TOXICOLOGY REVIEW
|
|
NETOX* 26,573,2005
|
TOXICOLOGY REVIEW
|
|
CCATAR 366,1,2006
|
TOXICOLOGY REVIEW
|
|
CCATAR 366,1,2006
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,583,2005
|
TOXICOLOGY REVIEW
|
|
MUREAV 627,10,2007
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,306,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,308,2005
|
TOXICOLOGY REVIEW
|
|
REPTED 23,260,2007
|
TOXICOLOGY REVIEW
|
|
FEREAC 72,44439,2007
|
TOXICOLOGY REVIEW
|
|
FEREAC 72,44439,2007
|
TOXICOLOGY REVIEW
|
|
REPTED 26,1,2008
|
TOXICOLOGY REVIEW
|
|
JTPAE7 19,1,2006
|
TOXICOLOGY REVIEW
|
|
HUTOX* -,541,1996
|
TOXICOLOGY REVIEW
|
|
HTOPA* 1,501,2002
|
TOXICOLOGY REVIEW
|
|
MUREAV 681,3,2009
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Supported
|
RBREV* -,99,1998
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.2 mg/m3, JUL2008
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.1 mg/m3 (vapor, aerosol), Skin, MAR2002
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.2 mg/m3, OCT 2002
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.2 mg/m3, short term exposure limit 0.6 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.2 mg/m3, Skin, FEB2006
|
Occupational Exposure Limit - KOREA
|
time-weighted average 0.2 mg/m3, short term exposure limit 0.6 mg/m3, skin, 2006
|
Occupational Exposure Limit - MEXICO
|
time-weighted average 0.2 mg/m3; | short term exposure limit 0.6 mg/m3 (skin), 2004
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.2 mg/m3, Skin, 2003
|
Occupational Exposure Limit - NEW ZEALAND
|
time-weighted average 0.2 mg/m3, skin, JAN2002
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.2 mg/m3, JAN1999
|
Occupational Exposure Limit - POLAND
|
time-weighted average 0.2 mg/m3, short term exposure limit 0.6 mg/m3, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.2 mg/m3, DEC2006
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.2 mg/m3; | short term exposure limit 0.6 mg/m3 (skin), 2005
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not classifiable as human carcinogen
Occupational Exposure Limit IN SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not classifiable as human carcinogen | |||||||||||||||||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CHLORPYRIFOS-air
|
10 hour time-weighted average 0.2 mg/m3; | short term exposure limit 0.6 mg/m3 (Sk)
NIOSH* DHHS #95-121,1995
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: M4463; | Number of Industries 1; Total Number of Facilities 753; Number of Occupations 3; Total Number of Employees Exposed 22,523
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: T0714; | Number of Industries 1; Total Number of Facilities 7; Number of Occupations 1; Total Number of Employees Exposed 7
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: M4463 |
Number of Industries 4; Total Number of Facilities 1,276; Number of Occupations 3; Total Number of Employees Exposed 11,404; Total Number of Female Employees Exposed 842 | |||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/103088/AS)
|
EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9
|
EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; TRP reversion
|
EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis
|
EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal
|
Used for control of fire ants, turf and ornamental plant insects, mosquitoes, etc.
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Organophosphorus pesticides, 5600
|
OSHA ANALYTICAL METHOD #62
|
| |||||||||||||
REFERENCES:
CODEN
|
|
REFERENCE
30ZDA9
|
"Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971
|
APHRER
|
Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26-
1992-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ASTTA8
|
ASTM Special Technical Publication. (American Soc. for Testing Materials, 1916 Race St.,
Philadelphia, PA 19103) No.1- 1911-
|
BCLPT*
|
Basic & clinical pharmacology & toxicology (Copenhagen, Denmark : Nordic Pharmacological
Society Oxford, UK : Distributed by Blackwell Munksgaard) V.94- 2004-
|
CCATAR
|
Clinica Chimica Acta. (Elsevier Science B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1956-
|
CTOXAO
|
Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW.
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ENTOX*
|
Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
FMCHA2
|
Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094)
|
HTOPA*
|
|
HUTOX*
|
|
INJPD2
|
Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221
005, India) V.1- 1968(?)-
|
JAFCAU
|
Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office
Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953-
|
JEENAI
|
Journal of Economic Entomology. (Entomological Soc. of America, 4603 Calvert Rd., College
Park, MD 20740) V.1- 1908-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
JTCTDW
|
Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY
10016) V.19- 1982-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
JTEHF8
|
Journal of Toxicology and Environmental Health, Part A. (Taylor & Francis, 47 Runway Rd.,
Suite G, Levittown, PA 19057) V.53- 1998-
|
JTPAE7
|
Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi-
shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988
|
JTSCDR
|
Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor,
Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NETEEC
|
Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.9- 1987-
|
NETOX*
|
NeuroToxicology (Amsterdam : Elsevier Science) V.1- 1979-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
PBBHAU
|
Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426,
Fayetteville, NY 13066) V.1- 1973-
|
PPTHFJ
|
Pulmonary Pharmacology and Therapeutics (London Academic Press, 32 Jamestown Road, London NW1
7BY United Kingdom) V. 10, Feb. 1997-
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
RREVAH
|
Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
07094) V.1- 1962-
|
RTOPDW
|
Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1981-
|
TERPM*
|
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOPADD
|
Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical
Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOVEFN
|
Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
USXXAM
|
United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
|
VHTODE
|
Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology,
Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
|
YKYUA6
|
Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950-
|
| |